BTIG initiates ImmunityBio stock with Buy rating, cites potential of ...

6 days ago · On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company's lead product, …

$6.00
OFF

BTIG Initiates ImmunityBio Stock With Buy Rating, Cites Potential Of ...

2 weeks from now

6 days ago · On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company's lead product, …

investing.com

93%
OFF

ImmunityBio (NASDAQ:IBRX) Earns Buy Rating From Analysts At …

2 weeks from now

6 days ago · The brokerage set a "buy" rating and a $6.00 price target on the stock. BTIG Research's target price indicates a potential upside of 147.93% from the company's current …

marketbeat.com

$2.42
OFF

ImmunityBio (NASDAQ:IBRX) Earns Buy Rating From Analysts At …

2 weeks from now

2 days ago · Shares of IBRX stock opened at $2.42 on Friday. The stock’s fifty day simple moving average is $3.96 and its 200 day simple moving average is $4.33. ImmunityBio has a one year …

etfdailynews.com

$6
OFF

ImmunityBio Initiated With A Buy At BTIG | Markets Insider

2 weeks from now

6 days ago · BTIG analyst Justin Zelin initiated coverage of ImmunityBio (IBRX) with a Buy rating and $6 price target Lead product Anktiva is approved in BCG-unresponsive non-muscle …

businessinsider.com

$6
OFF

BTIG Initiates Coverage On ImmunityBio With Buy Rating, $6 Price …

2 weeks from now

BTIG has initiated coverage on ImmunityBio with a buy rating and a $6 price target [1]. This positive outlook from BTIG comes on the heels of the company's recent achievements and …

ainvest.com

38%
OFF

BTIG Initiates Coverage Of ImmunityBio (IBRX) With Buy ... - Nasdaq

2 weeks from now

Dec 23, 2024 · Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.. Analyst Price Forecast Suggests 499.38% …

nasdaq.com

38%
OFF

BTIG Initiates Coverage Of ImmunityBio (IBRX) With Buy ... - Fintel

2 weeks from now

5 days ago · Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation. Analyst Price Forecast Suggests 499.38% …

fintel.io

$6.00
OFF

BTIG Starts Immunitybio Inc (IBRX) At Buy - Streetinsider.com

2 weeks from now

5 days ago · BTIG analyst Justin Zelin initiates coverage on Immunitybio Inc (NASDAQ: IBRX) with a Buy rating and a price target of $6.00.The analyst comments "WHAT YOU SHOULD …

streetinsider.com

$30.00
OFF

EF Hutton Sets Stock Target With Buy Rating For ImmunityBio, Cites ...

2 weeks from now

Oct 23, 2024 · The firm issued a Buy rating with a price target of $30.00, signaling confidence in the company’s potential. ImmunityBio's lead product, Anktiva, is at the forefront of the …

investing.com

$6
OFF

ImmunityBio: BTIG Initiates At 'Buy' Rating, The Target Price Is $6

2 weeks from now

5 days ago · Use AInvest stock screener to build watchlists and to make optimal investment decisions. ... BTIG initiates coverage on 'Buy' rating on ImmunityBio(IBRX). The target price is …

ainvest.com

$6.00
OFF

BTIG Initiates ImmunityBio Stock With Buy Rating, Cites Potential Of ...

2 weeks from now

6 days ago · On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company’s lead product, …

investing.com

$6
OFF

BTIG Initiates Coverage On ImmunityBio With Buy Rating, …

2 weeks from now

6 days ago · BTIG analyst Justin Zelin initiates coverage on ImmunityBio (NASDAQ:IBRX) with a Buy rating and announces Price Target of $6.

sahmcapital.com

$3
OFF

ImmunityBio Plans Public Stock Offering - Investing.com

2 weeks from now

Dec 10, 2024 · CULVER CITY, Calif. - ImmunityBio, Inc. (NASDAQ: IBRX), a $3.2 billion market cap immunotherapy company currently trading at $4.64, announced its intention to launch a …

investing.com

$21.00
OFF

BTIG Maintains Buy Rating On INmune Bio Shares With Steady Price …

2 weeks from now

Sep 18, 2024 · BTIG has reiterated its Buy rating and $21.00 price target for INmune Bio Inc. (NASDAQ: INMB), highlighting the company's innovative approach to Alzheimer's disease …

investing.com

FAQs about BTIG initiates ImmunityBio stock with Buy rating, cites potential of ... Coupon?

Should you buy immunitybio (IBRX)?

Out of the 3 analysts, 1 has given a hold rating, 1 has given a buy rating, and 1 has given a strong buy rating for IBRX. According to the 3 analysts' twelve-month price targets for ImmunityBio, the average price target is $17.38. The highest price target for IBRX is $30.00, while the lowest price target for IBRX is $4.75. ...

How much does immunitybio stock cost?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for ImmunityBio is $17.38, with a high forecast of $30.00 and a low forecast of $4.75. Should I buy or sell ImmunityBio stock right now? ...

Did institutional investors change their positions in immunitybio?

A number of institutional investors have recently made changes to their positions in the business. State Street Corp raised its position in shares of ImmunityBio by 10.1% during the third quarter. ...